Search - tctmd.com

Displaying 81 - 100 of 150

Sort: Relevancy | Date

Presentation TVT 2019

Proportionate and Disproportionate FMR: A New Conceptual Framework to Explain Differences in Clinical Trial Outcomes

Presenter: Paul Grayburn

June 13, 2019

Presentation TVT 2019

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Presenter: Gregg Stone

June 13, 2019

Presentation TVT 2019

Case Presentation and Clinical Device Discussion

Presenter: Saibal Kar

June 12, 2019

Presentation TVT 2019

Case Intervention and Outcomes

Presenter: Saibal Kar

June 12, 2019

Presentation TVT 2019

Anatomic Analysis TTE/TEE and Panel Discussion

Presenter: Maurice Sarano

June 12, 2019

News Conference News ESC Heart Failure 2019

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

Shelley Wood

May 27, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

Presentation JIM 2019

Functional Mitral Regurgitation in Patients with Chronic Heart Failure results of the REDUCE-FMR study

Presenter: Klaus Witte

February 15, 2019

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

REDUCE-FMR: Summary and Clinical Implications

Presenter: Andreas Baumbach, Stephan Windecker, Horst Sievert

September 23, 2018

Presentation TCT 2018

Pivotal Transcatheter FMR Device Trials: Focus on COAPT and MITRA-FR, with Implications for Other Transcatheter Mitral Valve Device Investigations

Presenter: Michael J. Mack, Changfu Wu, Gregg W. Stone

September 23, 2018

Presentation TCT 2018

REDUCE-FMR: A Sham-Controlled Randomized Trial of Transcatheter Mitral Valve Indirect Annuloplasty in Patients With Heart Failure and Secondary Mitral Regurgitation

Presenter: Martin B. Leon, Horst Sievert

September 23, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News PCR London Valves 2018

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

Presentation The Structural Heart Disease Summit 2018

The Goal of FMR Treatment: Reduction or Elimination of MR?

Presenter: Randall C. Starling

June 21, 2018

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Presenter: Steven F. Bolling, John C Laschinger, Ori Ben-Yehuda

October 31, 2017

Presentation TCT 2017

Flash Debate: MitraClip Should Not Be Crowned King of FMR Until COAPT and Other RCT Results!

Presenter: Ted Feldman, Scott Lim, Patrick M. McCarthy

October 30, 2017

News Industry News

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

June 16, 2017

Advertisement

Proportionate and Disproportionate FMR: A New Conceptual Framework to Explain Differences in Clinical Trial Outcomes

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Case Presentation and Clinical Device Discussion

Case Intervention and Outcomes

Anatomic Analysis TTE/TEE and Panel Discussion

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Functional Mitral Regurgitation in Patients with Chronic Heart Failure results of the REDUCE-FMR study

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

REDUCE-FMR: Summary and Clinical Implications

Pivotal Transcatheter FMR Device Trials: Focus on COAPT and MITRA-FR, with Implications for Other Transcatheter Mitral Valve Device Investigations

REDUCE-FMR: A Sham-Controlled Randomized Trial of Transcatheter Mitral Valve Indirect Annuloplasty in Patients With Heart Failure and Secondary Mitral Regurgitation

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

The Goal of FMR Treatment: Reduction or Elimination of MR?

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Flash Debate: MitraClip Should Not Be Crowned King of FMR Until COAPT and Other RCT Results!

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content